Bristol Myers' (BMY) Boerner says they have 10 launch opportunities by 2030
Importance
Level 1
#BRISTOL-MYERS SQUIBB CO#BMY.US#EQUITIES#EU SESSION#US SESSION#PHARMACEUTICALS#PHARMACEUTICALS (GROUP)#PHARMACEUTICALS, BIOTECHNOLOGY & LIFE SCIENCES#S&P 500 INDEX#BMY#US EQUITIES